|A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood|
A Pfefferbaum, DH Mathalon, EV Sullivan, JM Rawles, RB Zipursky, ...
Archives of neurology 51 (9), 874-887, 1994
|Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia|
S Kapur, R Zipursky, C Jones, G Remington, S Houle
American Journal of Psychiatry 157 (4), 514-520, 2000
|Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia|
S Kapur, RB Zipursky, G Remington
American Journal of Psychiatry 156 (2), 286-293, 1999
|Antipsychotic drug effects on brain morphology in first-episode psychosis|
JA Lieberman, GD Tollefson, C Charles, R Zipursky, T Sharma, RS Kahn, ...
Archives of general psychiatry 62 (4), 361-370, 2005
|Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis|
TH McGlashan, RB Zipursky, D Perkins, J Addington, T Miller, SW Woods, ...
American Journal of Psychiatry 163 (5), 790-799, 2006
|Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study|
A Pfefferbaum, KO Lim, RB Zipursky, DH Mathalon, MJ Rosenbloom, ...
Alcoholism: Clinical and Experimental Research 16 (6), 1078-1089, 1992
|Widespread cerebral gray matter volume deficits in schizophrenia|
RB Zipursky, KO Lim, EV Sullivan, BW Brown, A Pfefferbaum
Archives of general psychiatry 49 (3), 195-205, 1992
|Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected|
O Agid, S Kapur, T Arenovich, RB Zipursky
Archives of general psychiatry 60 (12), 1228-1235, 2003
|A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy|
S Kapur, R Zipursky, C Jones, CS Shammi, G Remington, P Seeman
Archives of general psychiatry 57 (6), 553-559, 2000
|Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol|
JA Lieberman, G Tollefson, M Tohen, AI Green, RE Gur, R Kahn, ...
American Journal of Psychiatry 160 (8), 1396-1404, 2003
|5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation|
S Kapur, RB Zipursky, G Remington, C Jones, J DaSilva, AA Wilson, ...
American Journal of Psychiatry 155 (7), 921-928, 1998
|Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study|
K McKenna, G Koren, M Tetelbaum, L Wilton, S Shakir, O Diav-Citrin, ...
The Journal of clinical psychiatry 66 (4), 444-449, 2005
|A systematic review of longitudinal outcome studies of first-episode psychosis|
NM Menezes, T Arenovich, RB Zipursky
Psychological medicine 36 (10), 1349, 2006
|The myth of schizophrenia as a progressive brain disease|
RB Zipursky, TJ Reilly, RM Murray
Schizophrenia bulletin 39 (6), 1363-1372, 2013
|Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation|
ZJ Daskalakis, BK Christensen, R Chen, PB Fitzgerald, RB Zipursky, ...
Archives of general psychiatry 59 (4), 347-354, 2002
|Increased dopamine D 2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study|
S Silvestri, MV Seeman, JC Negrete, S Houle, CM Shammi, ...
Psychopharmacology 152 (2), 174-180, 2000
|High levels of dopamine D₂ receptor occupancy with low-dose haloperidol treatment: A PET study.|
S Kapur, G Remington, C Jones, A Wilson, J DaSilva, S Houle, R Zipursky
The American journal of psychiatry, 1996
|The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study|
S Kapur, G Remington, RB Zipursky, AA Wilson, S Houle
Life Sciences 57 (10), PL103-PL107, 1995
|A longitudinal study of neurocognitive function in individuals at-risk for psychosis|
RSE Keefe, DO Perkins, H Gu, RB Zipursky, BK Christensen, ...
Schizophrenia research 88 (1-3), 26-35, 2006
|A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis|
J Addington, I Epstein, L Liu, P French, KM Boydell, RB Zipursky
Schizophrenia research 125 (1), 54-61, 2011